A small pilot trial demonstrated safety and efficacy for adults with chronic psychopathology and supports specific neurobiological mechanisms that can be normalized using therapeutic ketogenic diet and ketamine.
New Results: First RCT for Schizophrenia & Bipolar Disorder. Learn more.